
FTC Files Amicus Brief Highlighting Anticompetitive Harm from Improperly Listed Patents in FDA’s ‘Orange Book’
The Federal Trade Commission (FTC) filed an amicus brief on November 20, 2023, addressing the anticompetitive harm resulting from improperly listed patents in the Food and Drug Administration’s (FDA) “Approved …
FTC Files Amicus Brief Highlighting Anticompetitive Harm from Improperly Listed Patents in FDA’s ‘Orange Book’ Read More